USPTO serial 79352262
SANRO HEALTH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 2, 2024
- Examiner
- VAGHANI, MAYUR C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SANRO HEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew S. Ehard
P.O. Box 2910Minneapolis, MN 55402UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer software for use in the encryption and decryption of digital files; downloadable computer software for computer system and application development, deployment and management; downloadable computer software for use in the exchange of data between healthcare provider software and hardware and cloud-based software; downloadable computer software for the extraction of data from healthcare software and hardware; downloadable computer software using artificial intelligence for use in software development; downloadable computer software for use by health care providers, researchers, pharmaceutical companies or patients to improve efficiencies in the conducting of clinical trials; software as a medical device (samd), downloadable, for diagnosing, treating or monitoring of ophthalmic, immunologic, rheumatologic, urologic, cardiovascular, neurologic or genetic disease | ACTIVE | — |
| 042 | Consulting services in the field of software as a service (SaaS); software as a service (SaaS) services featuring artificial intelligence software for extracting and generating data, database management, and analysis of data and information for use in the fields of health care and pharmaceutical consultancy and research; software as a service (SaaS) services, namely, hosting software for use by others for database management, and analysis of data and information in the fields of clinical trials, pharmaceutical and medical research; computer software development; installation of computer software; online provision of non-downloadable web-based software that enables users to improve efficiencies in the conducting of clinical trials; conducting research and clinical trials for others relating to medical devices or pharmaceuticals in the fields of ophthalmology, immunology, rheumatology, urology, cardiovascular medicine, neurology or genetics; medical and scientific research, namely, conducting clinical trials for others; pharmaceutical research and development; consulting services in the field of pharmaceutical research and development; pharmaceutical product evaluation being services for assessing the efficiency and safety of pharmaceuticals; consultancy pertaining to pharmacology; advisory services relating to product quality testing; providing medical research information in the fields of pharmaceuticals and clinical trials; consulting services for others in the fields of design, planning, and implementation project management of scientific research and clinical trials; research for development of new products being pharmaceuticals; database design and development; providing virtual computer systems and virtual computer environments through cloud computing; scientific research consulting in the fields of ophthalmology, immunology, rheumatology, urology, cardiovascular medicine, neurology or genetics; providing quality assurance consultancy services in the fields of medical research and clinical trials; consultancy in the field of artificial intelligence technology; research in the field of artificial intelligence technology; information technology (IT) consulting services; testing, analysis and evaluation of the goods and services of others to determine conformity with certification standards | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sanro Health Holdings Pty Ltd
- Other trademarks owned by Sanro Health Holdings Pty Ltd
- Other trademarks owned by Sanro Health Holdings Pty Ltd
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named SANRO HEALTH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 2, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 16, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 16, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 3, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 2, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 2, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 1, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 13, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 13, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 16, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 16, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 13, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 27, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 27, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 27, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 8, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 7, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 7, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 7, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 4, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jun 9, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 8, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 28, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 27, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 24, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 25, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 21, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 20, 2022 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Oct 13, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |